Predictive value of Thomsen-Friedenreich antigen activation for Streptococcus pneumoniae infection and severity in pediatric lobar pneumonia

Journal of Microbiology, Immunology and Infection

Volumn 52, Issue 4, 2019, Pages 571-577

  Chang, Chia Jung ^a   Chiu, Nan Chang ^a,c   Huang, Fu Yuan ^a   Tsung Ning Huang, Daniel ^a   Chang, Lung ^a   Huang, Ching Ying ^a   Kung, Yen Hsin ^a   Chi, Hsin ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b Mackay Medicine College   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

Empyema; Parapneumonic effusion; Pediatric; Streptococcus pneumoniae; Thomsen Friedenreich antigen

Indexed keywords

C REACTIVE PROTEIN; CELL ANTIGEN; HEMOGLOBIN; THOMSEN FRIEDENREICH ANTIGEN; UNCLASSIFIED DRUG; THOMSEN-FRIEDENREICH ANTIGEN; TUMOR ANTIGEN;

AGE; ARTICLE; CHILD; DECORTICATION; DISEASE SEVERITY; EFFUSION; EMPYEMA; FEMALE; FEVER; GENDER; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; LOBAR PNEUMONIA; LUNG ABSCESS; MAJOR CLINICAL STUDY; MALE; NECROTIZING PNEUMONIA; PLATELET COUNT; PLEURA EFFUSION; PNEUMOCOCCAL INFECTION; PREDICTIVE VALUE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROTYPE; STREPTOCOCCUS PNEUMONIA; THORACOSTOMY; VIDEO ASSISTED THORACOSCOPIC SURGERY; ADOLESCENT; BLOOD; COMPLICATION; DIAGNOSTIC IMAGING; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INFANT; LUNG; PATHOGENICITY; PEDIATRICS; PROCEDURES; RISK FACTOR; STATISTICAL MODEL; STREPTOCOCCUS PNEUMONIAE; TAIWAN;

ADOLESCENT; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; EMPYEMA; FEMALE; FEVER; HUMANS; IMMUNOLOGIC TESTS; INFANT; LEUKOCYTE COUNT; LOGISTIC MODELS; LUNG; MALE; PEDIATRICS; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; TAIWAN; THORACOSTOMY;

EID: 85029214116     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2017.08.011     Document Type: Article

References (29)

1. Stein, R.T., Marostica, P.J., Community-acquired pneumonia: a review and recent advances. Pediatr Pulmonol 42 (2007), 1095–1103.
2. Michelow, I.C., Olsen, K., Lozano, J., Rollins, N.K., Duffy, L.B., Ziegler, T., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 113 (2004), 701–707.
3. Hsieh, Y.C., Hsueh, P.R., Lu, C.Y., Lee, P.I., Lee, C.Y., Huang, L.M., Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis 38 (2004), 830–835.
4. Erlichman, I., Breuer, O., Shoseyov, D., Cohen-Cymberknoh, M., Koplewitz, B., Averbuch, D., et al. Complicated community acquired pneumonia in childhood: different types, clinical course, and outcome. Pediatr Pulmonol 52 (2017), 247–254.
5. Ramasethu, J., Luban, N., T activation. Br J Haematol 112 (2001), 259–263.
6. Novak, R.W., Martin, C.R., Orsini, E.N., Hemolytic-uremic syndrome and T-cryptantigen exposure by neuraminidase-producing pneumococci: an emerging problem?. Pediatr Pathol 1 (1983), 409–413.
7. Crookston, K.P., Reiner, A.P., Cooper, L.J., Sacher, R.A., Blajchman, M.A., Heddle, N.M., RBC T activation and hemolysis: implications for pediatric transfusion management. Transfus (Paris) 40 (2000), 801–812.
8. Huang, C.Y., Chang, L., Liu, C.C., Huang, Y.C., Chang, L.Y., Huang, Y.C., et al. Risk factors of progressive community-acquired pneumonia in hospitalized children: a prospective study. J Microbiol Immunol Infect 48 (2015), 36–42.
9. Hardie, W., Bokulic, R., Garcia, V.F., Reising, S.F., Christie, C.D., Pneumococcal pleural empyemas in children. Clin Infect Dis 22 (1996), 1057–1063.
10. Osborn, D.A., Lui, K., Pussell, P., Jana, A.K., Desai, A.S., Cole, M., T and Tk antigen activation in necrotising enterocolitis: manifestations, severity of illness, and effectiveness of testing. Arch Dis Child Fetal Neonatal Ed 80 (1999), F192–F197.
11. Huang, D.T., Chi, H., Lee, H.C., Chiu, N.C., Huang, F.Y., T-antigen activation for prediction of pneumococcus-induced hemolytic uremic syndrome and hemolytic anemia. Pediatr Infect Dis J 25 (2006), 608–610.
12. Langley, J.M., Kellner, J.D., Solomon, N., Robinson, J.L., Le Saux, N., McDonald, J., et al. Empyema associated with community-acquired pneumonia: a pediatric Investigator's collaborative network on infections in Canada (PICNIC) study. BMC Infect Dis, 8, 2008, 129.
13. Deiros Bronte, L., Baquero-Artigao, F., Garcia-Miguel, M.J., Hernandez Gonzalez, N., Pena Garcia, P., del Castillo Martin, F., Parapneumonic pleural effusion: an 11-year review. An Pediatr (Barc) 64 (2006), 40–45.
14. Arancibia, M.F., Vega-Briceno, L.E., Pizarro, M.E., Pulgar, D., Holmgren, N., Bertrand, P., et al. Empyema and pleural effusion in children. Rev Chil Infectol 24 (2007), 454–461.
15. Seger, R., Joller, P., Baerlocher, K., Hitzig, W.H., Neuraminidase-producing pneumococci in the pathogenesis of hemolytic-uremic syndrome. Schweiz Med Wochenschr 110 (1980), 1454–1456.
16. Singh, A.K., Osman, A.S., Woodiga, S.A., White, P., Mahan, J.D., King, S.J., Defining the role of pneumococcal neuraminidases and O-glycosidase in pneumococcal haemolytic uraemic syndrome. J Med Microbiol 65 (2016), 975–984.
17. Smith, A., Johnston, C., Inverarity, D., Slack, M., Paterson, G.K., Diggle, M., et al. Investigating the role of pneumococcal neuraminidase A activity in isolates from pneumococcal haemolytic uraemic syndrome. J Med Microbiol 62 (2013), 1735–1742.
18. Reichert, M., Hecker, M., Witte, B., Bodner, J., Padberg, W., Weigand, M.A., et al. Stage-directed therapy of pleural empyema. Langenbecks Arch Surg 402 (2017), 15–26.
19. Eltringham, G., Kearns, A., Freeman, R., Clark, J., Spencer, D., Eastham, K., et al. Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1. J Clin Microbiol 41 (2003), 521–522.
20. Hendrickson, D.J., Blumberg, D.A., Joad, J.P., Jhawar, S., McDonald, R.J., Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 27 (2008), 1030–1032.
21. Chibuk, T., Cohen, E., Robinson, J., Mahant, S., Hartfield, D., Paediatric complicated pneumonia: diagnosis and management of empyema. Paediatr Child Health 16 (2011), 425–429.
22. Light, R.W., Parapneumonic effusions and empyema. Proc Am Thorac Soc 3 (2006), 75–80.
23. McGraw, M.E., Lendon, M., Stevens, R.F., Postlethwaite, R.J., Taylor, C.M., Haemolytic uraemic syndrome and the Thomsen Friedenreich antigen. Pediatr Nephrol 3 (1989), 135–139.
24. Chen, Y.Y., Yao, S.M., Chou, C.Y., Chang, Y.C., Shen, P.W., Huang, C.T., et al. Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002–2003. J Med Microbiol 55 (2006), 1109–1114.
25. Hsueh, P.R., Chen, H.M., Lu, Y.C., Wu, J.J., Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan. J Formos Med Assoc 95 (1996), 29–36.
26. Hsieh, Y.C., Huang, Y.C., Lin, H.C., Ho, Y.H., Chang, K.Y., Huang, L.M., et al. Characterization of invasive isolates of Streptococcus pneumoniae among Taiwanese children. Clin Microbiol Infect 15 (2009), 991–996.
27. Wei, S.H., Chiang, C.S., Chiu, C.H., Chou, P., Lin, T.Y., Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 34 (2015), e71–e77.
28. Chiang, C.S., Chen, Y.Y., Jiang, S.F., Liu, D.P., Kao, P.H., Teng, H.J., et al. National surveillance of invasive pneumococcal diseases in Taiwan, 2008–2012: differential temporal emergence of serotype 19A. Vaccine 32 (2014), 3345–3349.
29. Su, W.J., Lo, H.Y., Chang, C.H., Chang, L.Y., Chiu, C.H., Lee, P.I., et al. Effectiveness of pneumococcal conjugate vaccines of different valences against invasive pneumococcal disease among children in taiwan: a nationwide study. Pediatr Infect Dis J 35 (2016), e124–e133.